NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00407-1414-94 — Iohexol 350 injection (IV contrast dye)AI (245 hospitals, 64,629–66,105 samples)
• NDC 00641-6080-25 — Ondansetron injection 4 mgAI (296 hospitals, 62,867–66,098 samples)
• NDC 00054-0046-41 — Ipratropium bromide 0.06% nasal sprayAI (560 hospitals, 64,661–66,002 samples)
• NDC 63323-0165-30 — Dexamethasone sodium phosphate injection, 120 mg per 30 mL vialAI (524 hospitals, 60,097–65,821 samples)
• NDC 42023-0105-01 — Methohexital 500 mg vialAI (819 hospitals, 63,301–65,812 samples)
• NDC 00143-9509-10 — Ketamine hydrochloride injection 100 mg per mL, 5 mL vialAI (521 hospitals, 63,410–65,723 samples)
• NDC 63323-0162-16 — Ketorolac tromethamine 30 mg/mL injectionAI (339 hospitals, 62,465–65,489 samples)
• NDC 00487-9901-30 — Albuterol sulfate nebulizer solutionAI (854 hospitals, 63,415–65,422 samples)
• NDC 00143-9525-01 — Dexmedetomidine IV infusion in salineAI (410 hospitals, 62,255–65,234 samples)
• NDC 00264-7635-00 — Potassium chloride in dextrose and saline IV solutionAI (489 hospitals, 63,300–65,154 samples)
• NDC 00407-2223-03 — Iodixanol contrast dye for intravenous useAI (64 hospitals, 64,997–65,105 samples)
• NDC 00409-5555-02 — Intravenous sodium bicarbonate solution 4.2%AI (426 hospitals, 62,878–65,101 samples)
• NDC 60505-0826-01 — Ipratropium bromide nasal sprayAI (396 hospitals, 63,732–65,100 samples)
• NDC 00944-2700-06 — Gammagard 20 g per 200 mL intravenous solutionAI (797 hospitals, 64,581–64,932 samples)
• NDC 00264-2304-00 — ACETIC ACID 0.25 % IRRIGATION SOLUTIONAI (209 hospitals, 63,923–64,913 samples)
• NDC 73293-0001-01 — Lidocaine 1% injection solutionAI (400 hospitals, 57,754–64,900 samples)
• NDC 00143-9784-10 — Flumazenil injection, 0.5 mg per 5 mLAI (598 hospitals, 63,435–64,866 samples)
• NDC 44206-0436-05 — Privigen immune globulin IV solution, 5 gram vialAI (957 hospitals, 63,546–64,698 samples)
• NDC 24208-0398-30 — Ipratropium bromide 0.03% nasal sprayAI (452 hospitals, 63,298–64,693 samples)
• NDC 00409-9094-41 — Fentanyl citrate injection, preservative-freeAI (418 hospitals, 45,751–64,561 samples)
• NDC 63323-0170-05 — Sodium phosphate injection (intravenous solution)AI (487 hospitals, 63,777–64,533 samples)
• NDC 63323-0162-02 — Ketorolac tromethamine 60 mg/2 mL injectionAI (691 hospitals, 60,072–64,329 samples)
• NDC 00407-1413-68 — Iohexol 300 contrast injection for imagingAI (151 hospitals, 59,958–64,287 samples)
• NDC 72611-0722-01 — Ketorolac 30 mg/mL injectionAI (340 hospitals, 60,454–64,243 samples)
• NDC 00409-4011-01 — Verapamil 2.5 mg/mL intravenous injectionAI (305 hospitals, 61,636–64,084 samples)
• NDC 00143-9506-01 — Etomidate injection, 2 mg/mLAI (469 hospitals, 61,908–63,969 samples)
• NDC 63323-0806-12 — Fentanyl injection, 50 mcg per mLAI (428 hospitals, 43,741–63,892 samples)
• NDC 60505-6142-00 — Cefazolin sodium injection 1 gramAI (585 hospitals, 58,352–63,842 samples)
• NDC 00409-9094-25 — Fentanyl citrate injection, preservative-freeAI (836 hospitals, 54,762–63,744 samples)
• NDC 60505-0827-01 — Ipratropium bromide 0.06% nasal sprayAI (418 hospitals, 62,504–63,701 samples)
• NDC 00409-1638-02 — Dexmedetomidine 100 mcg/mL IV solutionAI (447 hospitals, 61,599–63,561 samples)
• NDC 24208-0399-15 — Ipratropium nasal spray, 15 mL canisterAI (452 hospitals, 62,332–63,529 samples)
• NDC 00944-2700-13 — Immune globulin intravenous or subcutaneous solution, 30 grams per 300 mLAI (260 hospitals, 63,404–63,521 samples)
• NDC 00409-1755-50 — Marcaine with epinephrine 0.5% injectionAI (492 hospitals, 61,780–63,490 samples)
• NDC 54643-5650-02 — Multivitamin with vitamin K intravenous solutionAI (367 hospitals, 61,431–63,483 samples)
• NDC 60687-0405-79 — Ipratropium-albuterol nebulizer solutionAI (500 hospitals, 62,203–63,481 samples)
• NDC 24208-0539-20 — Acetylcholine 1% solution kitAI (989 hospitals, 62,393–63,419 samples)
• NDC 42023-0113-10 — Ketamine injection solution, 20 mL vialAI (695 hospitals, 61,447–63,418 samples)
• NDC 55566-2800-01 — Dinoprostone vaginal insert, 10 mgAI (842 hospitals, 62,397–63,414 samples)
• NDC 00338-0221-04 — Electrolyte-A intravenous (IV) fluid solutionAI (621 hospitals, 60,774–63,294 samples)
• NDC 00338-9543-04 — Intravenous saline solution (0.9% sodium chloride)AI (310 hospitals, 52,181–63,278 samples)
• NDC 00143-9508-10 — Ketamine hydrochloride injection 50 mg/mLAI (491 hospitals, 61,541–63,269 samples)
• NDC 00338-0357-03 — mannitol 20 % intravenous solutionAI (609 hospitals, 59,723–63,242 samples)
• NDC 00409-3795-01 — Ketorolac injection, 30 mg per mLAI (625 hospitals, 58,641–63,123 samples)
• NDC 36000-0148-10 — Flumazenil IV solution 0.5 mg per 5 mLAI (454 hospitals, 61,621–63,115 samples)
• NDC 00944-2700-12 — Immune globulin (IgG) 10% injectionAI (376 hospitals, 62,940–63,093 samples)
• NDC 76329-3340-01 — Atropine sulfate 1 mg/10 mL syringeAI (964 hospitals, 60,902–63,080 samples)
• NDC 63323-0165-02 — Dexamethasone sodium phosphate 4 mg/mL injectionAI (508 hospitals, 51,283–63,073 samples)
• NDC 00143-9506-10 — Etomidate intravenous injection, 2 mg/mLAI (527 hospitals, 61,342–62,818 samples)
• NDC 00143-9508-01 — Ketamine hydrochloride injection 50 mg/mLAI (431 hospitals, 61,196–62,744 samples)